Jakavi 15mg Tablet
Jakavi 15mg Tablet
Ruxolitinib (15mg)
Cheaper alternative availability
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
About This Medicine
Product description & overview
Jakavi 15mg Tablets: A Promising Treatment for Certain Conditions
Jakavi 15mg Tablets contain the active ingredient Ruxolitinib (15mg), a medication prescribed to manage certain conditions related to the immune system. These tablets are specifically designed for individuals diagnosed with myelofibrosis or polycythemia vera.
Ruxolitinib inhibits Janus kinase (JAK) enzymes, which are crucial components of immune signaling pathways. By blocking these enzymes, Jakavi effectively reduces the production and activity of inflammatory cells, leading to improved symptom management.
Benefits of Jakavi:
* Reduces symptoms associated with myelofibrosis and polycythemia vera, including fatigue, anemia, and bone pain.
* Improves quality of life by alleviating uncomfortable and debilitating symptoms.
Before initiating treatment with Jakavi, it is essential to consult a medical professional for proper diagnosis and guidance regarding dosage and potential side effects. This medication should be taken only as prescribed and in accordance with your doctor's recommendations.
Note: This product is intended for individuals diagnosed with specific conditions mentioned above. Please consult your physician before using this medicine.
Active composition
Ruxolitinib 15 mg
About Ruxolitinib
Ruxolitinib is a kinase inhibitor used to treat myelofibrosis and polycythemia vera. It works by blocking signals that promote cancer cell proliferation. Ruxolitinib is effective in managing hematological malignancies. In summary, Ruxolitinib is beneficial for treating specific blood cancers.
How It Works
Ruxolitinib inhibits Janus kinases (JAK1 and JAK2), reducing signaling pathways that promote cell growth and survival in myeloproliferative disorders.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Jakavi 15mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Pregnancy
Jakavi 15mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Driving
Jakavi 15mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Jakavi 15mg Tablet may be needed. Please consult your doctor. Use of Jakavi 15mg Tablet is not advised in patients with moderate to severe kidney disease.
Exercise Caution
Breastfeeding
Jakavi 15mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Kidney
Jakavi 15mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Jakavi 15mg Tablet may be needed. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Jakavi 15mg Tablet